Everand Logo

Welcome to Everand!

  • MoneyWeek

    Seven tips for the biotech boom

    Mar 04, 2022 2 minutes

    has been a big winner from Covid-19 vaccines. Sales rose over 200 times from just $60m in 2019 to an estimated $17.9bn in 2021. The end of the crisis will lead to these sales falling, but the fact that it trades at just five times forecast 2022 earnings suggests that these fears are already priced in. Booster jabs

    You’re reading a preview, subscribe to read more.

    More from MoneyWeek

    MoneyWeek2 min read
    Audi Updates A Classic
    The Audi A3 has been the “conservative and consistent, if somewhat predictable, option in the premium family hatchback class” since it was first rolled out in 1999, say Matt Prior and Felix Page in Autocar. “Now, halfway through its fourth generation
    MoneyWeek2 min read
    Patience With Moonshots Wears Thin
    Wall Street’s patience for the costly artificial intelligence (AI) arms race is waning, says Dealbook in The New York Times. Facebook-owner Meta recently reported its “best ever first-quarter earnings”, but that wasn’t enough to prevent a crushing se
    MoneyWeek1 min read
    Spain’s PM Adds To Toxic Political Atmosphere
    Spanish prime minister Pedro Sánchez (pictured) “inspired anxiety, bewilderment and right-wing hopes” last week when he reacted to the opening of a judicial investigation into his wife by declaring he was “considering quitting” his post, say Jason Ho

    Related Books & Audiobooks